Companies that own Omeros Corp.
Ingalls & Snyder LLC
5,613,487
11.56%
70,625
6.37%
06/30/2018
BlackRock Fund Advisors
3,656,458
7.53%
-17,403
0.01%
06/30/2018
The Vanguard Group, Inc.
2,077,340
4.28%
-156,487
0%
06/30/2018
Cormorant Asset Management LP
1,314,118
2.71%
0
2.4%
06/30/2018
SSgA Funds Management, Inc.
1,079,522
2.22%
-133,006
0%
06/30/2018
CPWM LLC
1,074,543
2.21%
51,015
5.18%
06/30/2018
Susquehanna Financial Group LLLP
955,143
1.97%
158,052
0.1%
06/30/2018
D. E. Shaw & Co. LP
906,527
1.87%
749,893
0.04%
06/30/2018
Northern Trust Investments, Inc.
618,533
1.27%
15,983
0%
06/30/2018
Millennium Management LLC
469,272
0.97%
469,272
0.02%
06/30/2018
| Address |
The Omeros Building
Seattle Washington 98119
United States
|
|
Employees
|
- |
| Website |
http://www.omeros.com |
| Updated |
07/08/2019 |
| Omeros Corp. operates as a biopharmaceutical company specializes in discovery, development, and commercializes of both small-molecule and protein therapeutics for large -market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA. |
